May 25, 2013 2:49 PM ET

Pharmaceuticals

Company Overview of Amira Pharmaceuticals, Inc.

Company Overview

Amira Pharmaceuticals, Inc., a molecule pharmaceutical company, focuses on the discovery and development of small molecular drugs to treat inflammatory and fibrotic/respiratory diseases related to bioactive lipid pathways. The company builds insights into various bioactive lipid pathways, such as leukotriene, prostaglandin, and lysophospholipid, as well as complex signaling processes that control chronic obstructive pulmonary, cardiovascular, and fibrotic diseases, as well as asthma. It offers AM103/AM803, which are oral inhibitors of 5-lipoxygenase-activating protein. The company was founded in 2005 and is headquartered in San Diego, California. As of September 7, 2011, Amira Pharmaceutical...

Detailed Description

9535 Waples Street

Suite 100

San Diego, CA 92121

United States

Founded in 2005

Phone:

858-228-4650

Fax:

858-558-8445

www.amirapharm.com

Key Executives for Amira Pharmaceuticals, Inc.

Chief Executive Officer and Director
Age: 46
Co-Founder
Chief Financial Officer
Age: 58
Chief Business Officer
Vice President of Clinical Development
Compensation as of Fiscal Year 2012.

Similar Private Companies By Industry

Company Name Region
Genzyme Oncology, Inc. United States
Nanovis, Inc. United States
Boston Health Group Inc. United States
Amgen Manufacturing, Limited United States
Ruga Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Amira Pharmaceuticals, Inc., please visit www.amirapharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.